Item SpecimenName Subject Timepoint SubsetName SubsetDescription 1 525_E00_Tcell_mem 525 E00 Tcell_Memory Sorted live memory CD4 and CD8 T cells. 2 673_E00_Tcell_mem 673 E00 Tcell_Memory Sorted live memory CD4 and CD8 T cells. 3 684_E00_Tcell_mem 684 E00 Tcell_Memory Sorted live memory CD4 and CD8 T cells. 4 754_E00_Tcell_mem 754 E00 Tcell_Memory Sorted live memory CD4 and CD8 T cells. 5 761_E00_Tcell_mem 761 E00 Tcell_Memory Sorted live memory CD4 and CD8 T cells. 6 782_E00_Tcell_mem 782 E00 Tcell_Memory Sorted live memory CD4 and CD8 T cells. 7 836_E00_Tcell_mem 836 E00 Tcell_Memory Sorted live memory CD4 and CD8 T cells. 8 525_E00_Tcell_nai 525 E00 Tcell_Naive Sorted live naïve CD4 and CD8 T cells. 9 673_E00_Tcell_nai 673 E00 Tcell_Naive Sorted live naïve CD4 and CD8 T cells. 10 684_E00_Tcell_nai 684 E00 Tcell_Naive Sorted live naïve CD4 and CD8 T cells. 11 754_E00_Tcell_nai 754 E00 Tcell_Naive Sorted live naïve CD4 and CD8 T cells. 12 761_E00_Tcell_nai 761 E00 Tcell_Naive Sorted live naïve CD4 and CD8 T cells. 13 782_E00_Tcell_nai 782 E00 Tcell_Naive Sorted live naïve CD4 and CD8 T cells. 14 836_E00_Tcell_nai 836 E00 Tcell_Naive Sorted live naïve CD4 and CD8 T cells. 15 525_E03_CD4_total 525 E03 CD4_Total Live CD3+CD4+CD8- cells bulk-sorted from timepoint E03 16 673_E03_CD4_total 673 E03 CD4_Total Live CD3+CD4+CD8- cells bulk-sorted from timepoint E03 17 684_E03_CD4_total 684 E03 CD4_Total Live CD3+CD4+CD8- cells bulk-sorted from timepoint E03 18 754_E03_CD4_total 754 E03 CD4_Total Live CD3+CD4+CD8- cells bulk-sorted from timepoint E03 19 761_E03_CD4_total 761 E03 CD4_Total Live CD3+CD4+CD8- cells bulk-sorted from timepoint E03 20 782_E03_CD4_total 782 E03 CD4_Total Live CD3+CD4+CD8- cells bulk-sorted from timepoint E03 21 836_E03_CD4_total 836 E03 CD4_Total Live CD3+CD4+CD8- cells bulk-sorted from timepoint E03 22 525_E03_CD4_CD69_CD137 525 E03 AIM_CD69+CD137+ Live, CD3+CD4+CD8- cells co-expressing CD69 and CD137 after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "classic AIM-positive cells" in manuscript. 23 673_E03_CD4_CD69_CD137 673 E03 AIM_CD69+CD137+ Live, CD3+CD4+CD8- cells co-expressing CD69 and CD137 after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "classic AIM-positive cells" in manuscript. 24 684_E03_CD4_CD69_CD137 684 E03 AIM_CD69+CD137+ Live, CD3+CD4+CD8- cells co-expressing CD69 and CD137 after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "classic AIM-positive cells" in manuscript. 25 754_E03_CD4_CD69_CD137 754 E03 AIM_CD69+CD137+ Live, CD3+CD4+CD8- cells co-expressing CD69 and CD137 after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "classic AIM-positive cells" in manuscript. 26 761_E03_CD4_CD69_CD137 761 E03 AIM_CD69+CD137+ Live, CD3+CD4+CD8- cells co-expressing CD69 and CD137 after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "classic AIM-positive cells" in manuscript. 27 782_E03_CD4_CD69_CD137 782 E03 AIM_CD69+CD137+ Live, CD3+CD4+CD8- cells co-expressing CD69 and CD137 after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "classic AIM-positive cells" in manuscript. 28 836_E03_CD4_CD69_CD137 836 E03 AIM_CD69+CD137+ Live, CD3+CD4+CD8- cells co-expressing CD69 and CD137 after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "classic AIM-positive cells" in manuscript. 29 525_E03_CD4_CD154_CD134 525 E03 AIM_CD154_CD134 Live, CD3+CD4+CD8- cells expressing either CD69 or CD137 but not both, and further gated for expression of either CD134, CD154, or both, after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "additional AIM-positive cells" in manuscript. 30 673_E03_CD4_CD154_CD134 673 E03 AIM_CD154_CD134 Live, CD3+CD4+CD8- cells expressing either CD69 or CD137 but not both, and further gated for expression of either CD134, CD154, or both, after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "additional AIM-positive cells" in manuscript. 31 684_E03_CD4_CD154_CD134 684 E03 AIM_CD154_CD134 Live, CD3+CD4+CD8- cells expressing either CD69 or CD137 but not both, and further gated for expression of either CD134, CD154, or both, after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "additional AIM-positive cells" in manuscript. 32 754_E03_CD4_CD154_CD134 754 E03 AIM_CD154_CD134 Live, CD3+CD4+CD8- cells expressing either CD69 or CD137 but not both, and further gated for expression of either CD134, CD154, or both, after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "additional AIM-positive cells" in manuscript. 33 761_E03_CD4_CD154_CD134 761 E03 AIM_CD154_CD134 Live, CD3+CD4+CD8- cells expressing either CD69 or CD137 but not both, and further gated for expression of either CD134, CD154, or both, after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "additional AIM-positive cells" in manuscript. 34 782_E03_CD4_CD154_CD134 782 E03 AIM_CD154_CD134 Live, CD3+CD4+CD8- cells expressing either CD69 or CD137 but not both, and further gated for expression of either CD134, CD154, or both, after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "additional AIM-positive cells" in manuscript. 35 836_E03_CD4_CD154_CD134 836 E03 AIM_CD154_CD134 Live, CD3+CD4+CD8- cells expressing either CD69 or CD137 but not both, and further gated for expression of either CD134, CD154, or both, after 18 hour stimulation of PBMC with pooled SARS-CoV-2 S peptides. Termed "additional AIM-positive cells" in manuscript.